Cargando…

Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia

Detalles Bibliográficos
Autores principales: Fordham, S E, Cole, M, Irving, J A, Allan, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320285/
https://www.ncbi.nlm.nih.gov/pubmed/25249014
http://dx.doi.org/10.1038/leu.2014.284
_version_ 1782356098759524352
author Fordham, S E
Cole, M
Irving, J A
Allan, J M
author_facet Fordham, S E
Cole, M
Irving, J A
Allan, J M
author_sort Fordham, S E
collection PubMed
description
format Online
Article
Text
id pubmed-4320285
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43202852015-02-17 Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia Fordham, S E Cole, M Irving, J A Allan, J M Leukemia Letter to the Editor Nature Publishing Group 2015-02 2014-10-17 /pmc/articles/PMC4320285/ /pubmed/25249014 http://dx.doi.org/10.1038/leu.2014.284 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to the Editor
Fordham, S E
Cole, M
Irving, J A
Allan, J M
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
title Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
title_full Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
title_fullStr Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
title_full_unstemmed Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
title_short Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
title_sort cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320285/
https://www.ncbi.nlm.nih.gov/pubmed/25249014
http://dx.doi.org/10.1038/leu.2014.284
work_keys_str_mv AT fordhamse cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia
AT colem cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia
AT irvingja cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia
AT allanjm cytarabinepreferentiallyinducesmutationatspecificsequencesinthegenomewhichareidentifiableinrelapsedacutemyeloidleukaemia